leisure time -WSS

leisure time

author：entertainment 2025-09-27 10:04:40 - browse：791

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Eli Lilly expects to double planned employment in Boston center

hotspot

explore

WSS

ACIP vaccine advisory panel sees its vacancies filled

Study gives hint on South Asians’ higher risk of cardiovascular disease

Congress considering partial increase for doctor pay in Medicare

Tome Biosciences co

Congress must protect the remaining independent doctors

First Opinion Podcast: Long Covid needs a new approach

leisure time

leisure time

Wikipedia

The high cost of giving birth even with insurance

Doctors on social media are being harassed and cyberbullied

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth’s board chair also owns a personal investment firm

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Summit: GSK CEO on pharma giant's new direction

After affirmative action ruling, medical educators look to 'holistic review'

STAT Summit: Michael J. Fox on progress in Parkinson's research

The high cost of giving birth even with insurance

CEOs share strategies for surviving biotech slump

explore

Congress must protect the remaining independent doctors

STAT Summit: Michael J. Fox on progress in Parkinson's research

How climate

Solve the antibiotic resistance crisis with preventive drugs

First Opinion Podcast: Long Covid needs a new approach

How climate

hotspot

leisure time

explore

Wikipedia